Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Acquisitions & Divestments (2018 - 2019)

Apyx Medical's Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $40.9 million for Q2 2019.

  • For Q2 2019, Change in Acquisitions & Divestments changed N/A year-over-year to $40.9 million; the TTM value through Mar 2020 reached $40.9 million, down 37.68%, while the annual FY2019 figure was $80.7 million, 213.4% up from the prior year.
  • Change in Acquisitions & Divestments reached $40.9 million in Q2 2019 per APYX's latest filing, up from $39.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $40.9 million in Q2 2019 to a low of $25.8 million in Q4 2018.